Regeneron Pharmaceuticals
REGN
#279
Rank
NZ$137.43 B
Marketcap
NZ$1,300
Share price
-1.22%
Change (1 day)
-0.03%
Change (1 year)

Market capitalization of Regeneron Pharmaceuticals (REGN)

Market cap: NZ$137.43 Billion

As of March 2026 Regeneron Pharmaceuticals has a market cap of NZ$137.43 Billion. This makes Regeneron Pharmaceuticals the world's 279th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regeneron Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$137.43 B-4.33%
2025NZ$143.65 B3.49%
2024NZ$138.81 B-8.26%
2023NZ$151.30 B22.26%
2022NZ$123.75 B24.46%
2021NZ$99.43 B39.17%
2020NZ$71.44 B16.21%
2019NZ$61.48 B1.29%
2018NZ$60.69 B6.72%
2017NZ$56.87 B1.76%
2016NZ$55.89 B-32.66%
2015NZ$83.00 B54.77%
2014NZ$53.63 B60.63%
2013NZ$33.38 B65.03%
2012NZ$20.23 B207.72%
2011NZ$6.57 B72.79%
2010NZ$3.80 B40.93%
2009NZ$2.70 B7.15%
2008NZ$2.51 B1.36%
2007NZ$2.48 B33.43%
2006NZ$1.86 B41.91%
2005NZ$1.31 B82.1%
2004NZ$0.72 B-42.66%
2003NZ$1.25 B-20.12%
2002NZ$1.57 B-47.21%
2001NZ$2.98 B1.82%
2000NZ$2.92 B281.93%
1999NZ$0.76 B76.61%
1998NZ$0.43 B-4.87%
1997NZ$0.45 B-22.14%
1996NZ$0.58 B

End of Day market cap according to different sources

On Mar 9th, 2026 the market cap of Regeneron Pharmaceuticals was reported to be:

NZ$139.14 Billion
by Nasdaq info icon info icon
NZ$139.14 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$988.98 B 619.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$525.99 B 282.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
NZ$340.79 B 147.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$178.81 B 30.11%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$46.56 B-66.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$71.99 B-47.62%๐Ÿ‡บ๐Ÿ‡ธ USA